Fine Foods & Pharmaceuticals Ntm Logo

Fine Foods & Pharmaceuticals Ntm

A CSDMO specializing in solid oral forms for the pharma and nutraceutical sectors.

FF | XMIL

Overview

Corporate Details

ISIN(s):
IT0005215329 (+1 more)
LEI:
8156009111DEE8553765
Country:
Italy
Address:
VIA BERLINO, 39 (ZINGONIA), 24040 VERDELLINO

Description

Fine Foods & Pharmaceuticals Ntm is an integrated Contract Sales and Development Manufacturing Organization (CSDMO) specializing in the development and contract manufacturing of products for third parties. The company's core expertise is in solid oral forms for the pharmaceutical and nutraceutical sectors. Its services also extend to the production of medical devices, cosmetics, and biocides. The organization applies a principle of scientific rigor across all its operations, emphasizing technological innovation, manufacturing excellence, and quality. With a significant portion of its workforce dedicated to science, the company acts as a strategic manufacturing partner to support client growth.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-22 10:18
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 15 DICEMBRE–19 DICEMBRE 2025 /…
English 543.8 KB
2025-12-15 10:22
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 8 DICEMBRE–12 DICEMBRE 2025 / …
English 547.1 KB
2025-12-09 10:37
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 1 DICEMBRE–5 DICEMBRE 2025 / T…
Italian 478.4 KB
2025-12-01 17:17
Allegato 3F / Annex 3F
Italian 28.6 KB
2025-12-01 11:19
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 24 NOVEMBRE – 28 NOVEMBRE 2025…
Italian 470.8 KB
2025-11-24 10:10
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 17 NOVEMBRE – 21 NOVEMBRE 2025…
Italian 515.0 KB
2025-11-17 13:16
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 10 NOVEMBRE – 14 NOVEMBRE 2025…
Italian 466.2 KB
2025-11-11 15:15
Interim Financial Report as of 30 September 2025
Italian 448.5 KB
2025-11-10 10:42
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 3 NOVEMBRE – 7 NOVEMBRE 2025 /…
Italian 463.4 KB
2025-11-06 15:18
Resoconto intermedio di gestione al 30 settembre 2025
Italian 400.6 KB
2025-11-06 13:38
Fine Foods confirms growth trajectory: revenue +7%, Adjusted EBITDA was €30.5 m…
English 644.7 KB
2025-11-06 13:37
Fine Foods consolida il percorso di crescita: ricavi +7%, EBITDA Adj. a €30,5 m…
Italian 639.5 KB
2025-11-04 10:09
Allegato 3F / Annex 3F
Italian 28.7 KB
2025-11-03 11:31
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 27 OTTOBRE – 31 OTTOBRE 2025 …
Italian 471.5 KB
2025-10-27 11:19
INFORMATIVA SULL’ACQUISTO AZIONI PROPRIE PERIODO 20 OTTOBRE – 24 OTTOBRE 2025 /…
Italian 449.3 KB

Automate Your Workflow. Get a real-time feed of all Fine Foods & Pharmaceuticals Ntm filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Fine Foods & Pharmaceuticals Ntm

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Fine Foods & Pharmaceuticals Ntm via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.